PPARδ increases expression of the human apolipoprotein A-II gene in human liver cells

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 819-824

  Thulin, Petra ^a   Glinghammar, Björn ^b   Skogsberg, Josefin ^a   Lundell, Kerstin ^a   Ehrenborg, Ewa ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; APOA2 PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; THIAZOLE DERIVATIVE;

ARTICLE; BINDING SITE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVITY; GENE CONSTRUCT; GENE CONTROL; GENE MUTATION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPORTER GENE; CARBOHYDRATE METABOLISM; DNA RESPONSIVE ELEMENT; DRUG EFFECT; DRUG POTENTIATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETICS; LIPID METABOLISM; LIVER CELL CARCINOMA; METABOLISM; METHODOLOGY; MUTATION; PATHOLOGY; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

APOLIPOPROTEIN A-II; BASE SEQUENCE; BINDING SITES; CARBOHYDRATE METABOLISM; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMANS; LIPID METABOLISM; MUTATION; PPAR DELTA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RESPONSE ELEMENTS; SEQUENCE HOMOLOGY, NUCLEIC ACID; THIAZOLES;

EID: 47649084860     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.819     Document Type: Article

References (18)

1. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G and von Eckardstein A: HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161: 1-16, 2002.
2. Tailleux A, Duriez P, Fruchart JC and Clavey V: Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 164: 1-13, 2002.
3. Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA, Stroes ES, Otvos JD, Wareham NJ, Luben R, Kastelein JJ, Khaw KT and Boekholdt SM: Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 116: 2029-2035, 2007.
4. Barbier O, Torra IP, Duguay Y, Blanquart C, Fruchart JC, Glineur C and Staels B: Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 22: 717-726, 2002.
5. Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA and Desvergne B: DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J Biol Chem 272: 25252-25259, 1997.
6. Chambaz J, Cardot P, Pastier D, Zannis V and Cladaras C: Promoter elements and factors required for hepatic transcription of the human ApoA-II gene. J Biol Chem 266: 11676-11685, 1991.
7. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B and Auwerx J: Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 96: 741-750, 1995.
8. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC and Willson TM: A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98: 5306-5311, 2001.
9. Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM, Hassall DG, Ancellin N, Patterson SD, Lobe DC and Johnson TG: Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol 27: 359-365, 2007.
10. Barish GD, Narkar VA and Evans RM: PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest 116: 590-597, 2006.
11. Glinghammar B, Skogsberg J, Hamsten A and Ehrenborg E: PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 308: 361-368, 2003.
12. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M and Werner T: MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942, 2005.
13. Ovcharenko I, Loots GG, Giardine BM, Hou M, Ma J, Hardison RC, Stubbs L and Miller W: Mulan: Multiple-sequence local alignment and visualization for studying function and evolution. Genome Res 15: 184-194, 2005.
14. Lundell K, Thulin P, Hamsten A and Ehrenborg E: Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and transactivation ability. BMC Mol Biol 8: 70, 2007.
15. Ikewaki K, Zech LA, Kindt M, Brewer HB and Rader DJ Jr: Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler Thromb Vasc Biol 15: 306-312, 1995.
16. Clavey V, Copin C, Mariotte MC, Bauge E, Chinetti G, Fruchart J, Fruchart JC, Dallongeville J and Staels B: Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells. Cell Physiol Biochem, 9: 139-149, 1999.
17. Simpson JC, Wellenreuther R, Poustka A, Pepperkok R and Wiemann S: Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 1: 287-292, 2000.
18. Ladias JA, Hadzopoulou-Cladaras M, Kardassis D, Cardot P, Cheng J, Zannis V and Cladaras C: Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem 267: 15849-15860, 1992.